Newron Pharmaceuticals S.p.A. (0QOI.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 05:21PM BST
| Previous close | 7.28 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 4,223 |
| Market cap | 139.37M |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.85 |
| Earnings date | 19 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireNewron Pharmaceuticals Reports on Its 2024 Investor Day in New York City
MILAN & MORRISTOWN, N.J., June 25, 2024--Newron reports data from its 2024 Investor Day indicating evenamide would be uniquely effective in patients with treatment resistant schizophrenia
Business WireNewron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
MILAN & MORRISTOWN, N.J., June 18, 2024--Newron Pharmaceuticals to host its 2024 Investor Day on June 25, 2024, in New York City. Live webcast beginning at 9:00 AM EDT.
Business WireNewron Pharmaceuticals Will Host Its 2024 Investor Day on June 25 in New York City
MILAN & MORRISTOWN, N.J., June 05, 2024--Newron Pharmaceuticals will host its 2024 Investor Day on June 25 in New York City. New hope emerges for treatment-resistant schizophrenia.
© 2024 Yahoo. All rights reserved.